James P. Tursi
2017 - Aralez Pharmaceuticals
In 2017, James P. Tursi earned a total compensation of $1.1M as Chief Medical Officer at Aralez Pharmaceuticals, a 49% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $171,032 |
---|---|
Option Awards | $86,859 |
Salary | $412,000 |
Stock Awards | $433,565 |
Other | $10,280 |
Total | $1,113,736 |
Tursi received $433.6K in stock awards, accounting for 39% of the total pay in 2017.
Tursi also received $171K in non-equity incentive plan, $86.9K in option awards, $412K in salary and $10.3K in other compensation.
Rankings
In 2017, James P. Tursi's compensation ranked 8,465th out of 14,666 executives tracked by ExecPay. In other words, Tursi earned more than 42.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,465 out of 14,666 | 42nd |
Division Manufacturing | 3,207 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,066 out of 2,075 | 49th |
Industry group Drugs | 842 out of 1,731 | 51st |
Industry Pharmaceutical Preparations | 658 out of 1,333 | 51st |
Source: SEC filing on May 18, 2018.
Tursi's colleagues
We found five more compensation records of executives who worked with James P. Tursi at Aralez Pharmaceuticals in 2017.
2017
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
2017
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
2017
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
2017
Mark Glickman
Aralez Pharmaceuticals
Former Chief Commercial Officer
2017
Michael Kaseta
Aralez Pharmaceuticals